Dr. Barbey obtained her PhD from the University of Lausanne Switzerland. She brings to ReMedys a dual background in medical research and clinical drug development with 15 years experience in immunology research and clinical immunology and 8 years of clinical development in the pharmaceutical industry.
She has developed and implemented global clinical strategies for early (Ph0-I-II), late (PhIII) and post-marketing (PhIIb-IV) studies. She led several cross-functional projects, developing scientifically and medically rigorous clinical development plans (including trials conduct), common technical regulatory and medical communication documents, in line with the business strategy and needs. Dr. Barbey also has a broad research experience from her work in research hospitals where she managed several translational medicine projects in immunology. Dr. Barbey is involved in the clinical planning of all ReMedys projects.